Langerhans Cell Histiocytosis (LCH) - Adults

Recommendations for diagnosis, clinical work-up and treatment of adults; Version 1, August 2013

Euro Histio Net Work Group for LCH Guidelines: Michael Girschikofsky (Executive Editor)1; Maurizio Arico2, Diego Castillo3, Anthony Chu4, Claus Doberauer5, Joachim Fichter6, Julien Haroche7, Gregory A. Kaltsas8, Polyzois Makras9, Angelo V. Marzano10, Mathilde de Menthon11, Oliver Micke12, Emanuela Passoni10, M. Heinrich Seegenschmiedt13, Abdellatif Tazi14, Kenneth L. McClain15.

1: Internal Medicine I, Elisabethinen Hospital, Linz, Austria; 2: Department of Pediatric Hematology Oncology, Azienda Ospedaliero Universitaria A. Meyer, Florence, Italy; 3: Departament of Respiratory Medicine. Hospital de la Santa Creu i Sant Pau. Barcelona, Spain; 4: Imperial NHS Trust, London, UK; 5: Clinic for Internal Medicine, Protestant Clinics, Gelsenkirchen, Germany; 6: Paracelsus Klinik, Osnabrück, Germany; 7: Service de Medicine Interne, Groupe Hospitalier Pitie-Salpetiere, Paris, France; 8: Department of Pathophysiology, University of Athens School of Medicine, Athens, Greece; 9: Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece; 10: U.O. Dermatologia, Fondazione IRCCS Ca´ Granda-Ospedale Maggiore Policlinico, Milano, Italy; 11: Dept. of Internal Medicine, Hospital Saint Louis, Paris, France; 12: Franziskus Hospital, Department of Radiotherapy and Radiation Oncology, Bielefeld, Germany; 13: Radiation Oncology Center, Hamburg, Germany; 14: Pulmonolgy Dept, Saint Louis Teaching Hospital, Paris, France. 15: Texas Children´s Cancer Center/Hematology Service, Houston, TX, USA